£109.07

Peritoneal Carcinomatosis from Ovarian Cancer

Oncology

Price data last checked 146 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

Same price for 5 weeks. Today is much like next week.

£109 for 34 days straight · last change was Dec 2025

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 585 days • 585 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 585 days • 4 price ranges

Days at Price

Current Price

Price Analysis

Most common range: £136-145 (173 days, 29.6%)

Price range: £99 - £145

Price levels: 4 price ranges over 585 days

Description

Ovarian cancer is the most common cause of death among all gynecological neoplasms. Ovarian epithelial cancer represents approximately 90% of all ovarian malignant tumours. The most usual pattern of spread and probably the earliest kind of metastasis of ovarian cancer is intraperitoneal spread, caused by apoptosis of viable cancer cells, even in cases where the ovarian surface has no visible rupture. Approximately 70% to 75% of all ovarian cancers are being diagnosed with peritoneal carcinomatosis and ascites in advanced stages III and IV. Peritoneal carcinomatosis from ovarian cancer may occur either concomitantly with the primary tumour or as a recurrence pattern of spread. Standard treatment consists of surgical debulking and postoperative systemic chemotherapy. Response rates to first-line chemotherapy with platinum/taxane combinations are high, about 70-80%, but the vast majority of patients will relapse. Peritoneal seeding is a major cause of surgical treatment failure among those patients, even after optimal debulking. However, progressing ovarian cancer tends to remain within the peritoneal cavity or, better-expressed, ovarian cancer is a cancer of the peritoneum. The administration of cytotoxic agents directly into the peritoneal cavity as treatment for malignancy was initially evaluated more than 40 years ago. Over the past two decades regional therapy of ovarian cancer has evolved from just an interesting pharmacokinetic concept into a viable management option for women with advanced disease. Several authors, and among them some of the world's leading experts on this field present the current knowledge and their experience on peritoneal carcinomatosis from ovarian cancer.

Key Features

New

Mint Condition

Dispatch same day for order received before 12 noon

Guaranteed packaging

No quibbles returns

Product Specifications

Format: hardcover
ASIN: 1594543984
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Internal Medicine > Diseases & Disorders > Oncology
Domain: Amazon UK
Release Date: 08 April 2005
Listed Since: 05 February 2007

Barcode

No barcode data available

Peritoneal Carcinomatosis from Ovarian Cancer

Same price for 5 weeks. Today is much like next week.

Price History & Forecast

Price Distribution

Price Analysis

Description

Key Features

Product Specifications

Barcode

Similar Products You Might Like

Peritoneal Tumors and Metastases: Surgical, intraperitoneal and systemic therapy

Pathology of Peritoneal Metastases: The Unchartered Fields

Treatment of Peritoneal Surface Malignancies, An Issue of Surgical Oncology Clinics (Volume 21-4) (The Clinics: Surgery, Volume 21-4)

Peritoneal Carcinomatosis: A Multidisciplinary Approach: 134 (Cancer Treatment and Research, 134)

Treatment of Peritoneal Surface Malignancies: State of the Art and Perspectives (Updates in Surgery)

Peritoneal Carcinomatosis: Principles of Management: 82 (Cancer Treatment and Research, 82)

Peritoneal Carcinomatosis: Drugs and Diseases: 81 (Cancer Treatment and Research, 81)

Peritoneal Carcinomatosis: Principles of Management: 82 (Cancer Treatment and Research, 82)

A Practical Guide to Peritoneal Malignancy: The PMI Manual

A Practical Guide to Peritoneal Malignancy: The PMI Manual

Treatment of Peritoneal Metastasis, An Issue of Surgical Oncology Clinics of North America (Volume 27-3) (The Clinics: Surgery, Volume 27-3)

Management of Peritoneal Metastases- Cytoreductive Surgery, HIPEC and Beyond

Intraperitoneal Cancer Therapy (Current Clinical Oncology)

Pathology of the Ovary, Fallopian Tube and Peritoneum (Essentials of Diagnostic Gynecological Pathology)

PIPAC: Pressurized Intraperitoneal Aerosol Chemotherapy - Cancer Under Pressure (Phenomenology & Mind): 17

Intraperitoneal Therapy for Ovarian Cancer

Peritonitis: Causes, Diagnosis and Treatment (Emergency and Intensive Care Medicine)

Surgical Management of Advanced Pelvic Cancer

Peritoneal Dialysis: 2 (Developments in Nephrology)

Ovarian Cancer: Second Edition: 149 (Cancer Treatment and Research, 149)

Frontiers in Ovarian Cancer Science (Comprehensive Gynecology and Obstetrics)

Peritonitis

Abdominal Injuries: Risk Factors, Management & Prognosis

Surgery for Ovarian Cancer